Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

The amount of neoadjuvant chemotherapy for Barrett's carcinoma does not correlate with long-term survival.

Schauer M, Knoefel WT, Friess H, Theisen J.

J Gastrointest Surg. 2011 Oct;15(10):1750-5. doi: 10.1007/s11605-011-1623-6. Epub 2011 Aug 3.

PMID:
21811882
2.

Results of a multimodal therapy in patients with stage IV Barrett's adenocarcinoma.

Schauer M, Stein H, Lordick F, Feith M, Theisen J, Siewert JR.

World J Surg. 2008 Dec;32(12):2655-60. doi: 10.1007/s00268-008-9722-6.

PMID:
18802733
3.

Downstaging of T or N predicts long-term survival after preoperative chemotherapy and radical resection for esophageal carcinoma.

Korst RJ, Kansler AL, Port JL, Lee PC, Kerem Y, Altorki NK.

Ann Thorac Surg. 2006 Aug;82(2):480-4; discussion 484-5.

PMID:
16863749
4.

Efficacy and toxicity of fluorouracil, doxorubicin, and cisplatin/nedaplatin treatment as neoadjuvant chemotherapy for advanced esophageal carcinoma.

Kosugi S, Kanda T, Nakagawa S, Ohashi M, Nishimaki T, Hatakeyama K.

Scand J Gastroenterol. 2005 Aug;40(8):886-92.

PMID:
16170897
5.

Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm.

Pennathur A, Luketich JD, Landreneau RJ, Ward J, Christie NA, Gibson MK, Schuchert M, Cooper K, Land SR, Belani CP.

Ann Thorac Surg. 2008 Jun;85(6):1930-6; discussion 1936-7. doi: 10.1016/j.athoracsur.2008.01.097.

PMID:
18498797
6.

[Clinical analysis of 108 cases with adenocarcinoma Barretts's esophagus].

Han JQ, Liu Q, Liang RX, Qu FS, Yan TX, Sun YH, Li XQ.

Zhonghua Zhong Liu Za Zhi. 2007 Jun;29(6):470-3. Chinese.

PMID:
17974287
7.

Does Barrett's esophagus respond to chemoradiation therapy for adenocarcinoma of the esophagus?

Barthel JS, Kucera ST, Lin JL, Hoffe SE, Strosberg JR, Ahmed I, Dilling TJ, Stevens CW.

Gastrointest Endosc. 2010 Feb;71(2):235-40. doi: 10.1016/j.gie.2009.09.038. Epub 2009 Dec 8.

PMID:
20003971
8.

Neoadjuvant chemotherapy in Barrett's carcinoma - prognosis and response prediction.

Schauer M, Knoefel WT.

Anticancer Res. 2010 Apr;30(4):1065-70. Review.

PMID:
20530410
9.

Nodal metastasis from locally advanced esophageal cancer: how neoadjuvant therapy modifies their frequency and distribution.

Castoro C, Scarpa M, Cagol M, Ruol A, Cavallin F, Alfieri R, Zanchettin G, Rugge M, Ancona E.

Ann Surg Oncol. 2011 Dec;18(13):3743-54. doi: 10.1245/s10434-011-1753-9. Epub 2011 May 10.

PMID:
21556952
10.

Neoadjuvant chemoradiation versus chemotherapy for patients undergoing esophagectomy for esophageal cancer.

Luu TD, Gaur P, Force SD, Staley CA, Mansour KA, Miller JI Jr, Miller DL.

Ann Thorac Surg. 2008 Apr;85(4):1217-23; discussion 1223-4. doi: 10.1016/j.athoracsur.2007.11.070.

PMID:
18355499
11.

NF-kappaB activation in esophageal adenocarcinoma: relationship to Barrett's metaplasia, survival, and response to neoadjuvant chemoradiotherapy.

Abdel-Latif MM, O'Riordan J, Windle HJ, Carton E, Ravi N, Kelleher D, Reynolds JV.

Ann Surg. 2004 Apr;239(4):491-500.

12.

[Short and long-term outcomes of neoadjuvant chemotherapy for locally advanced esophageal carcinoma].

Xie MR, Zhang X, Lin P, Lin YB, Rong TH, Zhang LJ, Wen ZS, Li XD.

Zhonghua Yi Xue Za Zhi. 2009 Nov 10;89(41):2906-9. Chinese.

PMID:
20137647
13.

Does neoadjuvant chemoradiation downstage esophageal carcinoma?

Slater MS, Holland J, Faigel DO, Sheppard BC, Deveney CW.

Am J Surg. 2001 May;181(5):440-4.

PMID:
11448438
14.

Combined endoscopic mucosal resection and photodynamic therapy versus esophagectomy for management of early adenocarcinoma in Barrett's esophagus.

Pacifico RJ, Wang KK, Wongkeesong LM, Buttar NS, Lutzke LS.

Clin Gastroenterol Hepatol. 2003 Jul;1(4):252-7.

PMID:
15017665
15.

Treatment of Barrett's esophagus with early neoplasia: a comparison of endoscopic therapy and esophagectomy.

Schembre DB, Huang JL, Lin OS, Cantone N, Low DE.

Gastrointest Endosc. 2008 Apr;67(4):595-601. doi: 10.1016/j.gie.2007.08.042. Epub 2008 Feb 14.

PMID:
18279860
16.

Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response.

Machtay M, Lee JH, Stevenson JP, Shrager JB, Algazy KM, Treat J, Kaiser LR.

J Thorac Cardiovasc Surg. 2004 Jan;127(1):108-13.

17.

Pathologic response after neoadjuvant therapy is the major determinant of survival in patients with esophageal cancer.

Meredith KL, Weber JM, Turaga KK, Siegel EM, McLoughlin J, Hoffe S, Marcovalerio M, Shah N, Kelley S, Karl R.

Ann Surg Oncol. 2010 Apr;17(4):1159-67. doi: 10.1245/s10434-009-0862-1. Epub 2010 Feb 6.

PMID:
20140529
18.

[Multimodal therapy of tumors of the upper gastrointestinal tract].

Fink U, Stein HJ, Siewert JR.

Chirurg. 1998 Apr;69(4):349-59. Review. German.

PMID:
9612616
20.

Transthoracic esophagectomy with radical mediastinal and abdominal lymph node dissection and cervical esophagogastrostomy for esophageal carcinoma.

Swanson SJ, Batirel HF, Bueno R, Jaklitsch MT, Lukanich JM, Allred E, Mentzer SJ, Sugarbaker DJ.

Ann Thorac Surg. 2001 Dec;72(6):1918-24; discussion 1924-5.

PMID:
11789772

Supplemental Content

Support Center